Could abatacept directly target expanded plasmablasts in IgG4-related disease?
INSERM ESPRI, ERI29/EA2216, European University of Brittany, Brest, France Service de Rhumatologie, CHRU Brest, Brest, France.
Guillermo
G
Carvajal Alegria
INSERM ESPRI, ERI29/EA2216, European University of Brittany, Brest, France.
Pierre
P
Pochard
INSERM ESPRI, ERI29/EA2216, European University of Brittany, Brest, France.
Jacques-Olivier
JO
Pers
INSERM ESPRI, ERI29/EA2216, European University of Brittany, Brest, France Service de Rhumatologie, CHRU Brest, Brest, France.
Divi
D
Cornec
D000069594:Abatacept; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D010950:Plasma Cells
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D000069594:Abatacept
Autoimmune Diseases; B cells; DMARDs (biologic)